Atria Investments LLC Biogen Inc. Transaction History

Atria Investments LLC

$7.36 Billion
Q2 2024

A detailed history of Atria Investments LLC transactions in Biogen Inc. stock. As of the latest transaction made, Atria Investments LLC holds 4,365 shares of BIIB stock, worth $853,924. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,365

Holding current value

$853,924

% of portfolio

0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $831,619 - $1.03 Million	4,365 New	4,365 $1.01 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $973,608 - $1.17 Million	4,374 New	4,374 $1.13 Million
Q4 2021 Feb 04, 2022	SELL	$223.92 - $287.77 $1.75 Million - $2.24 Million	-7,793 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$282.99 - $369.05 $1.08 Million - $1.41 Million	3,830 Added 96.64%	7,793 $2.21 Million
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $595,700 - $953,833	-2,300 Reduced 36.72%	3,963 $1.37 Million
Q1 2021 May 11, 2021	SELL	$242.95 - $284.63 $550,767 - $645,256	-2,267 Reduced 26.58%	6,263 $1.75 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $621,127 - $934,951	2,629 Added 44.55%	8,530 $2.09 Million
Q3 2020 Nov 05, 2020	BUY	$264.77 - $305.71 $32,301 - $37,296	122 Added 2.11%	5,901 $1.67 Million
Q2 2020 Sep 22, 2020	BUY	$258.66 - $342.55 $43,196 - $57,205	167 Added 2.98%	5,779 $1.55 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $467,261 - $592,727	-1,738 Reduced 23.65%	5,612 $1.78 Million
Q4 2019 Feb 11, 2020	BUY	$220.06 - $304.07 $416,793 - $575,908	1,894 Added 34.71%	7,350 $2.18 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $100,457 - $112,672	-462 Reduced 7.81%	5,456 $1.27 Million
Q2 2019 Aug 26, 2019	BUY	$219.29 - $241.72 $1.3 Million - $1.43 Million	5,918 New	5,918 $1.35 Million
Q2 2019 Aug 09, 2019	SELL	$219.29 - $241.72 $1.73 Million - $1.91 Million	-7,902 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $174,018 - $272,184	803 Added 11.31%	7,902 $1.87 Million
Q4 2018 Feb 12, 2019	BUY	$278.5 - $352.75 $403,546 - $511,134	1,449 Added 25.65%	7,099 $2.14 Million
Q3 2018 Oct 09, 2018	BUY	$293.51 - $383.83 $560,604 - $733,115	1,910 Added 51.07%	5,650 $2 Million
Q2 2018 Jul 13, 2018	SELL	$257.52 - $306.91 $482,592 - $575,149	-1,874 Reduced 33.38%	3,740 $1.09 Million
Q1 2018 Apr 30, 2018	BUY	$260.13 - $367.91 $223,191 - $315,666	858 Added 18.04%	5,614 $1.54 Million
Q4 2017 Jan 16, 2018	BUY	$307.64 - $344.58 $292,258 - $327,351	950 Added 24.96%	4,756 $1.52 Million
Q3 2017 Oct 12, 2017	BUY	$281.15 - $329.69 $1.07 Million - $1.25 Million	3,806	3,806 $1.19 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$3.25 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$3.2 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.84 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.39 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$1.11 Billion
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.

Account